Entero Therapeutics, Inc. • ENTO

Capital at risk.

About Entero Therapeutics, Inc.
Ticker
info
ENTO
Trading on
info
NASDAQ
ISIN
info
US33749P4081
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Richard Joel Paolone
Headquarters
info
777 Yamato Road, Boca Raton, FL, United States, 33431
Employees
info
2
Website
info
enterothera.com
Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the digestion of fats and other nutrients in CF and CP patients with EPI. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.
Metrics
BasicAdvanced
Market cap
info
$1.8M
P/E ratio
info
-
EPS
info
-$8.07
Dividend Yield
info
0.00%
Beta
info
0.84
Forward P/E ratio
info
0
EBIDTA
info
$-7.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.8M
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
0.27
Earnings
EPS
info
-$8.07
EPS estimate (current quarter)
info
-$1.55
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-7.3M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
0.84
52-week High
info
$1.27
52-week Low
info
$0.19
50-day moving average
info
$0.43
200-day moving average
info
$0.50
Short ratio
info
0.1
Short %
info
6.06%
Management effectiveness
ROE (TTM)
info
-33.24%
ROA (TTM)
info
-5.21%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
4.8M
Float
info
4.4M
Insiders %
info
7.30%
Institutions %
info
3.07%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$36.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$3.37
-$1.55
-117.19%
Q2 • 24Missed
-$0.59
-$0.32
-83.00%
Q3 • 24Missed
-$2.59
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-12.2M
-∞%
Q4 • 24
$0M
$-1.3M
-∞%
Q1 • 25
NaN%
-89.71%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$85.4M
$27.6M
32.32%
Q4 • 24
$85.2M
$28.7M
33.73%
Q1 • 25
-0.24%
4.11%
4.36%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.2M
$0M
$-0M
$-0.2M
Q4 • 24
$-0.8M
$0M
$0.7M
$-0.8M
Q1 • 25
377.29%
-
-2,301.40%
377.29%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Entero Therapeutics, Inc. share?
Collapse

Entero Therapeutics, Inc. shares are currently traded for undefined per share.

How many shares does Entero Therapeutics, Inc. have?
Collapse

Entero Therapeutics, Inc. currently has 4.8M shares.

Does Entero Therapeutics, Inc. pay dividends?
Collapse

No, Entero Therapeutics, Inc. doesn't pay dividends.

What is Entero Therapeutics, Inc. 52 week high?
Collapse

Entero Therapeutics, Inc. 52 week high is $1.27.

What is Entero Therapeutics, Inc. 52 week low?
Collapse

Entero Therapeutics, Inc. 52 week low is $0.19.

What is the 200-day moving average of Entero Therapeutics, Inc.?
Collapse

Entero Therapeutics, Inc. 200-day moving average is $0.50.

Who is Entero Therapeutics, Inc. CEO?
Collapse

The CEO of Entero Therapeutics, Inc. is Richard Joel Paolone.

How many employees Entero Therapeutics, Inc. has?
Collapse

Entero Therapeutics, Inc. has 2 employees.

What is the market cap of Entero Therapeutics, Inc.?
Collapse

The market cap of Entero Therapeutics, Inc. is $1.8M.

What is the P/E of Entero Therapeutics, Inc.?
Collapse

The current P/E of Entero Therapeutics, Inc. is null.

What is the EPS of Entero Therapeutics, Inc.?
Collapse

The EPS of Entero Therapeutics, Inc. is -$8.07.

What is the PEG Ratio of Entero Therapeutics, Inc.?
Collapse

The PEG Ratio of Entero Therapeutics, Inc. is null.

What do analysts say about Entero Therapeutics, Inc.?
Collapse

According to the analysts Entero Therapeutics, Inc. is considered a buy.